Aryl-substituted benzo(d)isothiazol-3-ylamine analogues as capsaicin receptor modulators

Details for Australian Patent Application No. 2004259676 (hide)

Owner Neurogen Corporation

Inventors Zheng, Xiazhang; Blum, Charles A.

Agent Pizzeys

Pub. Number AU-A-2004259676

PCT Pub. Number WO2005/009982

Priority 60/485,958 10.07.03 US

Filing date 9 July 2004

Wipo publication date 3 February 2005

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 (2006.01) - Thiazoles

C07D 275/06 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/009982 Priority application(s): WO2005/009982

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259699-Drive for coverings for architectural openings

2004259675-Hydroxypyridine CGRP receptor antagonists